Concepedia
Statistics
Publications
5
Citations
118
H-Index
Active since
2014
Affiliations
IQVIA (United Kingdom)(Current)
Max Schlueter is an author at IQVIA (United Kingdom).
Publications per year
2014–2020
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden
Nathaniel Henry, Jelena Jovanović, Max Schlueter et al. · Journal of Medical Economics · 2017 · 31 citations · Full text
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception
Nathaniel Henry, Max Schlueter, Julia Lowin et al. · Journal of Family Planning and Reproductive Health Care · 2014 · 30 citations · Full text
The cost of cancer – A comparative analysis of the direct medical costs of cancer and other major chronic diseases in Europe
Max Schlueter, Katie Chan, Romain Lasry et al. · PLoS ONE · 2020 · 26 citations · Full text
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
G. Vega-Hernández, Radek Wojcik, Max Schlueter · Diabetes Therapy · 2017 · 20 citations · Full text
<p>Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain</p>
Max Schlueter, Elaine Finn, Silvia Díaz‐Cerezo et al. · ClinicoEconomics and Outcomes Research · 2019 · 11 citations · Full text
1–5 of 5